Check out American Heart Association CEO Nancy Brown's latest Huffington Post blog post about the need to address health disparities in clinical trials.
"Turn on your television at any point during the day or night and you will likely run across an ad for a prescription drug, along with a disclaimer about possible side effects. It seems only logical that those side effects are a possibility for anyone who takes the medicine, regardless of gender, race or age.
Unfortunately, that logic is wrong.
Studies of drugs and medical devices do not always report what effects these treatments may have on women, minorities or the elderly. Worse yet, those effects are not always investigated, as members of those populations are often underrepresented in trials -- despite the fact gender, race and age makes people more prone to certain diseases." Read the full article on the Huff Post Healthy Living Blog.
As more information is known about how medications and other medical products affect the patient, health care providers will be able to more appropriately meet the needs of patients. This article emphasizes the need to explore how medical products effect subsets within the larger population. While some members of the population may benefit from a particluar medical product, others may not, and may even be harmed as a result of a product. It is especially important to identify any patterns in adverse effects that may be associated with particular subsets of the population so that responsible medical products can be avoided in these subsets.